Despite its potential, cell therapy also faces several challenges. One major issue is the risk of cytokine release syndrome (CRS), a potentially severe immune reaction. Manufacturing and scaling up these therapies to meet clinical demand is another significant hurdle. Additionally, the high cost of treatment can be a barrier to accessibility for many patients. Ongoing research aims to address these challenges and improve the safety, efficacy, and affordability of cell therapies.
